Close menu
Brain & Behavior
Grants & Prizes
Home
Research
Illness
Addiction
Anxiety Disorders
Attention-Deficit Hyperactivity Disorder (ADHD)
Autism Spectrum Disorder (ASD)
Bipolar Disorder
Borderline Personality Disorder (BPD)
Depression
Eating Disorders
Mental Illness (General)
Obsessive-Compulsive Disorder (OCD)
Post-Traumatic Stress Disorder (PTSD)
Schizophrenia
Suicide Prevention
Other Brain-Related Illnesses
Category
Basic Research
New Technologies
Early Intervention/ Diagnostic Tools
Next Generation Therapies
Blog
Get Involved
Give
Donate Today
Memorial/Tribute (make donation)
Create Event or Memorial Page
Find a Memorial/Tribute Page
Planned Giving
Stock/Securities Donations / IRA Charitable Rollovers
Other Giving Opportunities
Research Partners
Workplace Giving
Team Up for Research!
Sponsorship Opportunities
Watch
Healthy Minds TV
Meet the Scientists Webinars
Videos
Connect
Ask the Expert
Join Us
Home
Grants
Grant FAQs
NARSAD Young Investigator Grants
NARSAD Independent Investigator Grants
NARSAD Distinguished Investigator Grants
Prizes & Awards
Klerman & Freedman Prizes
Outstanding Achievement Prizes
Lieber Prize for Schizophrenia Research
Maltz Prize for Schizophrenia Research
Colvin Prize for Mood Disorders Research
Ruane Prize for Child and Adolescent Psychiatric Research
Goldman-Rakic Prize for Cognitive Neuroscience Research
The Pardes Humanitarian Prize
Productive Lives Awards
Blog
About Us
Who We Are
Our Impact
FAQs
Media Center
News
Press Releases
Opinion Pieces
In the News
Publications
Multimedia Library
Media Kit
Events & Webinars
Team Up for Research! Events
Healthy Minds TV
Contact
Email Signup
Open Menu

Menu

Are there new medications for schizophrenia in the works?

Go Back to the Questions

Q. Are there new medications for schizophrenia in the works?

Marc G. Caron, Ph.D.
Answer By: Marc G. Caron, Ph.D.
James B. Duke Professor of Cell Biology,
Duke University Medical Center

Marc G. Caron, Ph.D., of the Duke University Medical Center received the Lieber Prize for Outstanding Achievement in Schizophrenia Research from the Brain & Behavior Research Foundation in 2013. Learn more about the Outstanding Achievement Prizes at: http://bbrfoundation.org/outstanding-achievement-prizes.

Tags:
Schizophrenia
Ask an Expert

Related Articles

Low Levels of Cannabinoid Receptor in New Psychosis Patients Suggest a Possible Drug Target

READ

Posted: Thursday, September 19, 2019

Low Levels of Cannabinoid Receptor in New Psychosis Patients Suggest a Possible Drug Target

Read more
A Way of Predicting if New Psychosis Patients Will or Won’t Respond to Standard Treatment

READ

Posted: Thursday, August 1, 2019

A Way of Predicting if New Psychosis Patients Will or Won’t Respond to Standard Treatment

Read more
RESEARCH FOR RECOVERY: Advances in Cognitive Remediation: ‘Helping Schizophrenia Patients Who Need It Most’

READ

Posted: Sunday, June 30, 2019

RESEARCH FOR RECOVERY: Advances in Cognitive Remediation: ‘Helping Schizophrenia Patients Who Need It Most’

Read more
A Rarely Studied Brain Structure Provides New Clues About Psychosis

READ

Posted: Thursday, June 27, 2019

A Rarely Studied Brain Structure Provides New Clues About Psychosis

Read more